{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:56:24Z","timestamp":1773338184168,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Eli Lilly and Company"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease which can present with mixed organ involvement. Kidney involvement in lupus nephritis (LN) is a severe complication and major cause of mortality in SLE patients, second only to cardiovascular disease. While mouse models have helped uncover some molecular pathways involved in SLE\/LN, we need a better understanding of the connection of these pathways and the immune cells involved in disease pathogenesis to develop new and effective therapies. Furthermore, models used for studying SLE\/LN in mice have a heterogeneous immune response and may not always represent disease manifestations observed in patients. Identifying models that have shared pathways with human disease would allow for better translation for developing effective SLE\/LN therapies. The molecular pathways of five different SLE\/LN models (MRL\/lpr, poly (I:C)-induced, interferon-\u03b1-induced, bm12 GvHD, and spontaneous NZB\/W F1) were compared to characterize the immune response in mouse kidneys. These models demonstrated varied magnitudes in immune responses and proportions of innate vs. adaptive cell involvement. These findings were compared to human molecular pathways and cell types from public databases, including the Accelerating Medicine Partnership\u2013Systemic Lupus Erythematosus Program (AMP-SLE), to help corelate mechanisms involved in mouse models to human disease.<\/jats:p>","DOI":"10.3390\/biology13100778","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T07:19:37Z","timestamp":1727680777000},"page":"778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Translating Lupus: Comparative Transcriptional Profiles of Preclinical Lupus Models and Their Relevance to Human Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"James T.","family":"Parker","sequence":"first","affiliation":[{"name":"Immunology Discovery Research, Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yun","family":"Chang","sequence":"additional","affiliation":[{"name":"Discovery Statistics, Eli Lilly and Company, Indianapolis, IN 46225, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Kersjes","sequence":"additional","affiliation":[{"name":"Immunology Discovery Research, Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ixavier A.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Discovery Statistics, Eli Lilly and Company, Indianapolis, IN 46225, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6466-348X","authenticated-orcid":false,"given":"Andrew C.","family":"Vendel","sequence":"additional","affiliation":[{"name":"Immunology Discovery Research, Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8389-780X","authenticated-orcid":false,"given":"William Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"Immunology Discovery Research, Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard.2010.135186","article-title":"Therapeutic opportunities in systemic lupus erythematosus: State of the art and prospects for the new decade","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.kint.2016.03.042","article-title":"Insights into the epidemiology and management of lupus nephritis from the US rheumatologist\u2019s perspective","volume":"90","author":"Hoover","year":"2016","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jama.1966.03100040091025","article-title":"NZB\/NZW mice as a model of systemic lupus erythematosus","volume":"195","author":"Dubois","year":"1966","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2006.02433.x","article-title":"Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus","volume":"119","author":"Liang","year":"2006","journal-title":"Immunology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/art.38047","article-title":"Suppression of glomerulonephritis in lupus-prone NZB \u00d7 NZW mice by RN486, a selective inhibitor of Bruton\u2019s tyrosine kinase","volume":"65","author":"LaStant","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.4049\/jimmunol.1301553","article-title":"Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis","volume":"191","author":"Rankin","year":"2013","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.4049\/jimmunol.0902391","article-title":"Protective and pathogenic roles for B cells during systemic autoimmunity in NZB\/W F1 mice","volume":"184","author":"Haas","year":"2010","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2119\/molmed.2016.00022","article-title":"The Effect of BAFF Inhibition on Autoreactive B-Cell Selection in Murine Systemic Lupus Erythematosus","volume":"22","author":"Boneparth","year":"2016","journal-title":"Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2006.01.007","article-title":"Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: Different effects on cytokines and apoptosis","volume":"119","author":"Sharabi","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1002\/art.21417","article-title":"Prevention and reversal of lupus in NZB\/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer","volume":"52","author":"Ye","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.4049\/jimmunol.174.5.2499","article-title":"IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB\/c mice","volume":"174","author":"Mathian","year":"2005","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.30087","article-title":"Interferon-\u03b1 accelerates murine systemic lupus erythematosus in a T cell-dependent manner","volume":"63","author":"Liu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.0914902107","article-title":"Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages","volume":"107","author":"Triantafyllopoulou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1073\/pnas.63.4.1102","article-title":"The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid","volume":"63","author":"Steinberg","year":"1969","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.4049\/jimmunol.1004142","article-title":"IFN-\u03b1 confers resistance of systemic lupus erythematosus nephritis to therapy in NZB\/W F1 mice","volume":"187","author":"Liu","year":"2011","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.176.6.1645","article-title":"Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci","volume":"176","author":"Watson","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"109317","DOI":"10.1016\/j.clim.2023.109317","article-title":"Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps","volume":"250","author":"Watanabe","year":"2023","journal-title":"Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ki.2015.196","article-title":"IL-3 contributes to development of lupus nephritis in MRL\/lpr mice","volume":"88","author":"Renner","year":"2015","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-1229(90)90040-W","article-title":"Experimental induction of systemic lupus erythematosus by recognition of foreign Ia","volume":"57","author":"Morris","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.161.11.5880","article-title":"The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease","volume":"161","author":"Chen","year":"1998","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, S.D., and Gant, T.W. (2008). A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-258"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yao, M., Gao, C., Zhang, C., Di, X., Liang, W., Sun, W., Wang, Q., and Zheng, Z. (2020). Identification of Molecular Markers Associated With the Pathophysiology and Treatment of Lupus Nephritis Based on Integrated Transcriptome Analysis. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.583629"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/rheumatology\/keaa187","article-title":"Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility","volume":"59","author":"Aue","year":"2020","journal-title":"Rheumatology"},{"key":"ref_28","unstructured":"NIAMS (2020, September 01). Accelerating Medicines Partnership\u00ae Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP\u00ae RA\/SLE) Program, Available online: https:\/\/www.niams.nih.gov\/grants-funding\/funded-research\/accelerating-medicines\/RA-SLE."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/0961203316652492","article-title":"A critical review of clinical trials in systemic lupus erythematosus","volume":"25","author":"Mahieu","year":"2016","journal-title":"Lupus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2006030263","article-title":"Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis","volume":"17","author":"Pawar","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.ki.5002625","article-title":"Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis","volume":"73","author":"Mathian","year":"2008","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cei.13017","article-title":"Renal-infiltrating CD11c(+) cells are pathogenic in murine lupus nephritis through promoting CD4(+) T cell responses","volume":"190","author":"Liao","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/immunohorizons.2100082","article-title":"Phenotypic Drift in Lupus-Prone MRL\/lpr Mice: Potential Roles of MicroRNAs and Gut Microbiota","volume":"6","author":"Bond","year":"2022","journal-title":"Immunohorizons"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e02288-17","DOI":"10.1128\/AEM.02288-17","article-title":"Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus","volume":"84","author":"Luo","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5152\/eurjrheum.2016.013","article-title":"Pauci-immune lupus nephritis: Possibility or co-incidence?","volume":"4","author":"Cansu","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0272-6386(12)80991-7","article-title":"Pauci-immune necrotizing lupus nephritis: Report of two cases","volume":"23","author":"Akhtar","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","article-title":"Mouse models of lupus: What they tell us and what they don\u2019t","volume":"5","author":"Richard","year":"2018","journal-title":"Lupus Sci. Med."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/10\/778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:05:51Z","timestamp":1760112351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/10\/778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["biology13100778"],"URL":"https:\/\/doi.org\/10.3390\/biology13100778","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]}}}